Tandem Diabetes Care, Inc. released its Q4 and full-year 2024 earnings after the bell yesterday, and the market has given the stock the thumbs down. Shares are down >30% in trading today, despite ...

Tandem Diabetes Care received Food and Drug Administration clearance for its Control-IQ+ algorithm in Type 2 diabetes. The automated insulin delivery (AID) system can pull data from glucose monitors ...

You may have heard of the screen tech before – its where pixels can switch themselves off completely for inky, perfect blacks. But there’s a new evolution to this screen tech on the scene, called ...